We are bringing curative living medicines to life to free patients from the siege of autoimmune disease.
Navigating what’s next in synthetic biology, immunology and cell engineering to create a new class of T cell therapies programmed to target and selectively modulate the underlying causes of autoimmunity.
Trailblazing Science Meets Unmet Patient Need
Kyverna is innovating cell therapy as a potentially curative approach to autoimmunity. Unlike current immunomodulatory treatments known to provide incremental disease control through chronic dosing, cell therapy holds the promise of modulating the immune system through a single – or relatively few – infusion(s) to achieve optimal and long-lasting disease control.